IV therapy at Regenerative Performance is for patients in three distinct groups: those using IV adjunctively to a regenerative procedure (PRP, stem cell), those addressing a chronic condition or nutrient deficiency where IV delivery is medically indicated, and those replenishing reserves after a high-stress period or lingering illness
December 2025: On December 15, 2025, the Judicial Panel on Multidistrict Litigation entered an order approving the creation of an MDL to house federal vision loss claims for Wegovy and other GLP-1 drugs
It is not, under any framing in any of the jurisdictions above, a clinical product, and any documentation written around it should reflect that
As part of the campaign, Williams is speaking out for the first time about using GLP-1 treatment to improve her health and help reach her weight goals after having kids
While overall maternal mortality remains low, the increasing occurrence of SAPespecially in individuals with multiple comorbid conditions and among certain ethnic groupswarrants increased clinical attention